SEC Form 4 · accession 0001104659-15-047705
STEMLINE THERAPEUTICS INC · STML
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ron Bentsur
Director
Period of report
Jun 23, 2015
Accepted (ET)
Jun 25, 2015 · 5:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001264587
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 23, 2015 | A | 10,000 | $0.00 | A | 17,285 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F2 | $12.76 | Jun 23, 2015 | A | 24,000 | A | Jun 23, 2016 | Jun 23, 2025 | Common Stock | 24,000 | 24,000 | D |
Explanation of responses
- F1The restricted shares will vest according to the following schedule: one-third on each of 6/23/2016, 6/23/2017, and 6/23/2018.
- F2The options will vest according to the following schedule: one-third on each of 6/23/2016, 6/23/2017, and 6/23/2018.